We estimate that the CEO of Inspire Medical Systems, Inc. ($INSP), Timothy P. Herbert, received a compensation of $7,711,784 in 2025. This is a decrease of -5.11% from an estimated $8,106,143 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on March 20, 2026. Note that parsing errors may occur.
You can track $INSP on Quiver Quantitative's $INSP stock dashboard.
$INSP Stock Insider Trading Activity
$INSP Stock insiders have traded $INSP stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $INSP stock by insiders over the last 6 months:
- SHAWN MCCORMICK has made 0 purchases and 2 sales selling 3,200 shares for an estimated $421,760.
- JOHN RONDONI (See Remarks) sold 109 shares for an estimated $10,900
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$INSP Stock Government Contracts
We have seen $3,721,713 of award payments to $INSP over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IMPLANTS: $142,010
- INSPIRE IMPLANTABLE PULSE GENERATOR V LEAD SLEEP REMOTE: $50,150
- SURGICAL IMPLANT: $50,150
- PROSTHETIC ORDER - IMPLANT ITEMS: $49,900
- IMPLANT FOR A VETERAN.: $47,336
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$INSP Stock Hedge Fund Activity
We have seen 197 institutional investors add shares of $INSP Stock stock to their portfolio, and 254 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,871,080 shares (-86.1%) from their portfolio in Q4 2025, for an estimated $264,799,708
- DRAGONEER INVESTMENT GROUP, LLC removed 2,354,411 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $174,697,296
- WELLINGTON MANAGEMENT GROUP LLP added 2,211,091 shares (+inf%) to their portfolio in Q4 2025, for an estimated $203,928,922
- CITADEL ADVISORS LLC removed 1,237,091 shares (-70.8%) from their portfolio in Q4 2025, for an estimated $114,096,902
- BAILLIE GIFFORD & CO removed 1,084,350 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $100,009,600
- M&T BANK CORP added 931,049 shares (+inf%) to their portfolio in Q4 2025, for an estimated $85,870,649
- D. E. SHAW & CO., INC. added 853,305 shares (+237.8%) to their portfolio in Q4 2025, for an estimated $78,700,320
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$INSP Stock Analyst Ratings
Wall Street analysts have issued reports on $INSP in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/12/2026
- RBC Capital issued a "Outperform" rating on 12/17/2025
- Stifel issued a "Buy" rating on 11/24/2025
- Piper Sandler issued a "Overweight" rating on 11/04/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
To track analyst ratings and price targets for $INSP Stock, check out Quiver Quantitative's $INSP forecast page.
$INSP Stock Price Targets
Multiple analysts have issued price targets for $INSP recently. We have seen 14 analysts offer price targets for $INSP in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- Jonathan Block from Stifel set a target price of $85.0 on 03/05/2026
- Mike Polark from Baird set a target price of $74.0 on 02/12/2026
- Adam Maeder from Piper Sandler set a target price of $85.0 on 02/12/2026
- Michael Sarcone from Jefferies set a target price of $66.0 on 02/12/2026
- Larry Biegelsen from Wells Fargo set a target price of $70.0 on 02/12/2026
- Anthony Petrone from Mizuho set a target price of $85.0 on 02/12/2026
- Richard Newitter from Truist Securities set a target price of $70.0 on 02/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
